• sold

    to

    The Valence Group acted as
    financial advisor to Safripol

    The Deal

    The Valence Group has advised Safripol Holdings Proprietary Limited (“Safripol”) on its sale to KAP Industrial Holdings Limited (“KAP”) for an enterprise value of ZAR4.1bn (c. US$310m).
    This successful intra-Africa sell-side transaction highlights the truly global nature of The Valence Group’s reach and capabilities.

  • has been sold to

    The Valence Group acted as
    financial advisor to Canexus

    The Deal

    The Valence Group has advised Canexus Corporation (TSX: CUS) on its sale to Chemtrade Logistics Income Fund (TSE: CHE.UN) for cash consideration of C$1.65 per common share, equivalent to an enterprise value of approximately C$900 million.
    The transaction, which has been unanimously approved by the Canexus Board of Directors, is structured as a Plan of Arrangement and is subject to regulatory and shareholder approval, as well as other customary closing conditions.
    Canexus is recommending shareholders vote in favor of the transaction and closing is expected before the end of April 2017.
    The Valence Group also provided a fairness opinion to the Board of Directors of Canexus.

  • has sold

    to

    The Valence Group acted as
    financial advisor to Dow

    The Deal

    The Valence Group has advised The Dow Chemical Company on the sale of SAFECHEM Europe GmbH to CBPE Capital LLP, a London-based private equity investor.
    SAFECHEM, headquartered in Düsseldorf, Germany, provides sustainable cleaning solutions, equipment and services for metal surface and dry cleaning applications to over 5,000 customers worldwide.
    The transaction was completed on December 31, 2016. Terms were not disclosed.
    The Valence Group also acted as financial advisor to Dow on the sale of its global Sodium Borohydride business to Wind Point Partners in February 2015.

  • has sold its
    expandable polystyrene
    business to

    The Valence Group acted as
    financial advisor to INEOS

    The Deal

    The Valence Group has advised INEOS Group AG on its sale of INEOS Styrenics, a producer of high quality expandable polystyrene for the building, construction and packaging industries, to Synthos S.A., one of the largest chemical companies in Poland and the CEE region.

  • has sold certain chlorvinyls businesses as a remedy to secure European Commission approval of INOVYN, their planned PVC JV, to

    The Valence Group acted as financial advisor to INEOS/Solvay

    The Deal

  • has sold its 65% interest in the Polymer Intermediates and Composite Resins businesses to

    The Valence Group acted as financial advisor to DSM

    The Deal

    The Valence Group has advised DSM on its exit from its Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins via the creation of a partnership with CVC

  • has sold its compounds business to

    The Valence Group acted as financial advisor to Tessenderlo

    The Deal

    The Valence Group has acted as M&A advisor to Tessenderlo Group on the intended sale of its Compounds activities to Mitsubishi Chemicals Corporation. Terms of the transaction were not disclosed.
    Tessenderlo’s Compounds business unit employs 360 people and focuses on the formulation and production of thermoplastic elastomers (TPE) and PVC compounds for the building, automotive, cabling, manufacturing and footwear industries. The sale comprises four production sites in France, Poland and China, and an R&D site in Belgium.

  • has sold

    to

    The Valence Group acted as advisor to DSM/Exxon

    The Deal

    Royal DSM, the global Life Sciences and Materials Sciences company, has reached an agreement with Borealis AG for the sale of DEXPlastomers V.o.F, a 50/50 Joint Venture of DSM with an affiliate of ExxonMobil Chemical. DSM will also sell its LldPE Compact Solution Technology to Borealis. Established in 1996, DEXPlastomers is a 50/50 joint venture between DSM and Exxon Chemical Holland Ventures B.V., producing C8 plastomers and linear low density polyethylene. DSM’s LldPE Compact Solution Technology was developed in the 1960’s to produce polyethylenes in a certain density range and is instrumental to the operations of DEXPlastomers. In 2012, DEXPlastomers anticipates sales of approximately €180 million. Currently, 95 DSM employees are in the scope of the transaction. For DSM, a sale of DEXPlastomers is in line with its long-term focus of being a Life Sciences and Materials Sciences company, active in health, nutrition and materials. DSM’s 50% participation in DEXPlastomers is reported under Corporate Activitie

  • has sold

    to Dynaplast Management

    The Valence Group acted as financial advisor to Tessenderlo

    The Deal

    Dynaplast-Extruco was formed in 2001 by the merger of two existing companies that were established in 1988 and 1989. Management bought Dynaplast-Extruco from Tessenderlo in 2011.

    The Valence Group acted as Financial Advisor to Tessenderlo.

  • has sold its PVC and Chlor-Alkali business to

    The Valence Group acted as financial advisor to Tessenderlo

    The Deal

    The Valence Group has successfully advised Tessenderlo Group (NYSE Euronext: TESB) on its sale of the PVC and Chlor-Alkali activities to INEOS subsidiary Kerling.

    Kerling, through its INEOS ChlorVinyls business, will purchase Tessenderlo Groups PVC activities, including VCM, Chlor-Alkali and part of Organic Chlorine Derivatives. Besides the major plant at Tessenderlo in Belgium, the production plants in France (Mazingarbe) and the Netherlands (Beek and Maastricht) are involved. These businesses employ about 850 people. This transaction is subject to European merger control approval.

    The purchase price is 110 million Euros on a cash-free, debt-free basis.

    Frank Coenen, CEO of Tessenderlo Group, emphasised that INEOSChlorVinyls will be an excellent owner of these activities: In light of our announced strategy - focusing on specialities - we looked for a long time for the right home for these businesses. Our well-invested assets together with our highly competent workforce are both strengths that were recognized by INEOSChlorVinyls. As a European leader, INEOSChlorVinyls is well placed to offer these businesses the best possible growth opportunities.

  • has sold its 50% ownership interest in SunBelt Chlor Alkali Partnership to

    The Valence Group acted as financial advisor to PolyOne

    The Deal

    The Valence Group has advised PolyOne Corp (NYSE:POL) on the successful sale of its 50% interest in SunBelt Chlor Alkali Partnership to Olin Corporation.

    SunBelt, a chlor alkali manufacturer, is a 50/50 joint venture formed in 1996 between PolyOne (formerly The Geon Company) and Olin. PolyOnes stake in SunBelt was sold to Olin for $175 million, including $132 million in cash and the assumption of PolyOnes guarantee of $43 million of SunBelt debt, with an additional earn out over the next three years if certain performance metrics are achieved. I am pleased with the completion of this strategic win / win transaction for both Olin and PolyOne, said Stephen D. Newlin, chairman, president and chief executive officer of PolyOne. I would like to thank Olin for the many years of cooperative partnership we have enjoyed together and wish them well as they integrate SunBelt into their operations. Newlin added, For PolyOne, the sale of SunBelt represents another step in our transformation and portfolio repositioning as we intend to use the proceeds to accelerate specialty platform growth.

    Mr. Newlin added: I would also like to thank The Valence Group for their support and counsel on this transaction. They are a highly valued M&A adviser to PolyOne, we have worked with the principals of The Valence Group in the past (most notably on the GLS acquisition) and we look forward to working with them in the future as we grow our specialties businesses.

    Telly Zachariades, Partner, commented: PolyOne is a core and long-standing client. We are very grateful for the opportunity to work with such an outstanding management team.

    PolyOne Corporation, with 2010 revenues of $2.6 billion, is a premier provider of specialized polymer materials, services and solutions. Headquartered outside of Cleveland, Ohio USA, PolyOne has operations around the world.

  • has sold its Building Block Chemicals division to

    The Valence Group acted as financial advisor to Cytec

    The Deal

    The Valence Group has successfully advised Cytec Industries, Inc. (NYSE: CYT) on the sale of its Building Block Chemicals Business , with 2010 sales of $600 million, to an affiliate of HIG Capital, LLC. Total consideration to be received of $180 million includes cash consideration of $165 million at closing and a Note for $15 million. The sale is subject to customary closing conditions.

    The Building Block Chemicals product lines include acrylonitrile, sulfuric acid and melamine which are produced mostly for third party sale.

    Telly Zachariades, Partner added: Working with a leading global specialty chemical company like Cytec is extremely gratifying. This is a significant transaction in the development of The Valence Group and evidence of our continuing increase in stature and market presence in the industry.

    Cytec Industries, Inc. (NYSE: CYT) is a publicly traded specialty chemical and material technologies company serving a diverse range of end markets including aerospace composites, structural adhesives, automotive and industrial coatings, chemical intermediates, electronics, inks, mining and plastics.

Deals

Safripol sold to KAP
Canexus sold to Chemtrade
Dow sells Safechem
INEOS Styrenics sold to Synthos
Ineos & Solvay sell Chlorvinyls Businesses
DSM sells part of its Polymer Intermediates and Composite Resins businesses to CVC
Tessenderlo sell Compounds Business to Mitsubishi
DSM sells DEXPlastomers JV to Borealis
Tessenderlo sells Dynaplast Extruco
Tessenderlo sells PVC and Chlor-Alkali businesses to INEOS
PolyOne sells SunBelt Investment
Cytec sells Building Block Chemicals division to H.I.G

All Deals - Commodity